The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications | Zendy

Diane M. Parente | Zendy; Cheston B. Cunha | Zendy; Eleftherios Mylonakis | Zendy; Tristan T. Timbrook | Zendy

Open Access

The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications

Author(s) -

Diane M. Parente,

Cheston B. Cunha,

Eleftherios Mylonakis,

Tristan T. Timbrook

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy024

Subject(s) - medicine , pneumonia , methicillin resistant staphylococcus aureus , staphylococcus aureus , antimicrobial stewardship , bacterial pneumonia , intensive care medicine , antibiotics , antibiotic resistance , microbiology and biotechnology , biology , bacteria , genetics

Recent literature has highlighted methicillin-resistant Staphylococcus aureus (MRSA) nasal screening as a possible antimicrobial stewardship program tool for avoiding unnecessary empiric MRSA therapy for pneumonia, yet current guidelines recommend MRSA therapy based on risk factors. The objective of this meta-analysis was to evaluate the diagnostic value of MRSA nasal screening in MRSA pneumonia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research